(Pyrazolylmethyl)pyridine platinum(II) and gold(III) complexes: Synthesis, structures and evaluation as anticancer agents

被引:34
|
作者
Segapelo, Tebogo V. [1 ]
Guzei, Ilia A. [2 ]
Spencer, Lara C. [2 ]
Van Zyl, Werner E. [1 ]
Darkwa, James [1 ]
机构
[1] Univ Johannesburg, Dept Chem, ZA-2006 Johannesburg, South Africa
[2] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA
关键词
(Pyrazol-1-ylmethyl)pyridine ligands; Platinum complexes; Gold complexes; C-H activation; Antitumor activity; TUMOR-CELL LINES; X-RAY STRUCTURES; SOLUTION CHEMISTRY; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; DNA-BINDING; IN-VITRO; DITHIOCARBAMATE DERIVATIVES; COPPER(II) COMPLEXES; BIPYRIDYL LIGANDS;
D O I
10.1016/j.ica.2009.02.046
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Reactions of 2-(3,5-dimethylpyrazol-1-ylmethyl)pyridine (L1), 2-(3,5-diphenylpyrazol-1-ylmethyl)pyridine (L2), 2-(3,5-di-tert-butylpyrazol-1-ylmethyl)pyridine (L3) and 2-(3-p-tolylpyrazol-1-ylmethyl)pyridine (L4) with K-2[PtCl4] in a mixture of ethanol and water formed the dichloro platinum complexes [PtCl2(L1)] (1), [PtCl2(L2)] (2), [PtCl2(L3)] (3) and [PtCl2(L4)] (4). Complex 1, [PtCl2(L1)], could also be prepared in a mixture of acetone and water. Performing the reactions of L2 and L3 in a mixture of acetone and water, however, led to C-H activation of acetone under mild conditions to form the neutral acetonyl complexes [Pt(CH2COCH3) Cl(L2)] (2a) and [Pt(CH2COCH3) Cl(L3)] (3a). The same ligands reacted with HAuCl4 center dot 4H(2)O in a mixture of ethanol and water to form the gold salts [AuCl2(L1)][AuCl4] (5) [AuCl2(L2)][Cl] (6) [AuCl2(L3)][Cl] (7) and [AuCl2(L4)][AuCl4] (8); however, with the pyrazolyl unit in the para position of the pyridinyl ring in 4-(3,5-dimethylpyrazol-1-ylmethyl)pyridine (L5), 4-(3,5-diphenylpyrazol-1-ylmethyl)pyridine (L6) neutral gold complexes [AuCl3(L5)] (9) and [AuCl2(L6)] (10) were formed; signifying the role the position of the pyrazolyl group plays in product formation in the gold reactions. X-ray crystallographic structural determination of L6, 2, 3 3a, 8 and 10 were very important in confirming the structures of these compounds; particularly for 3a and 8 where the presence of the acetonyl group confirmed C-H activation and for 8 where the counter ion is AuCl4-. Cytotoxicity studies of L2, L4 and complexes 1-10 against HeLa cells showed the Au complexes were much less active than the Pt complexes. (C) 2009 Elsevier B. V. All rights reserved.
引用
收藏
页码:3314 / 3324
页数:11
相关论文
共 50 条
  • [21] Synthesis and evaluation of copper(II) complexes with isoniazid-derived hydrazones as anticancer and antitubercular agents
    Firmino, Gisele S. S.
    de Souza, Marcus V. N.
    Pessoa, Claudia
    Lourenco, Maria C. S.
    Resende, Jackson A. L. C.
    Lessa, Josane A.
    BIOMETALS, 2016, 29 (06) : 953 - 963
  • [22] Rhodium(III) and iridium(III) complexes as anticancer agents
    Geldmacher, Yvonne
    Oleszak, Melanie
    Sheldrick, William S.
    INORGANICA CHIMICA ACTA, 2012, 393 : 84 - 102
  • [23] Recent advances and therapeutic journey of pyridine-based Cu(II) complexes as potent anticancer agents: a review (2015-2022)
    Alshamrani, Meshal
    JOURNAL OF COORDINATION CHEMISTRY, 2023, 76 (01) : 1 - 19
  • [24] Anticancer Profile of a Series of Gold(III) (2-phenyl)pyridine Complexes
    Rubbiani, Riccardo
    Zehnder, Thomas N.
    Mari, Cristina
    Blacque, Olivier
    Venkatesan, Koushik
    Gasser, Gilles
    CHEMMEDCHEM, 2014, 9 (12) : 2781 - 2790
  • [25] Synthesis, spectroscopic, molecular docking, theoretical calculations, DNA-binding, and anticancer activity studies of gold (III), platinum (II), palladium (II), and ruthenium (III) complexes with Girard-T reagent
    Al-Radadi, Najlaa S.
    El-Gamil, Mohammed M.
    APPLIED ORGANOMETALLIC CHEMISTRY, 2023, 37 (11)
  • [26] Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents
    Masternak, Joanna
    Gilewska, Agnieszka
    Barszcz, Barbara
    Lakomska, Iwona
    Kazimierczuk, Katarzyna
    Sitkowski, Jerzy
    Wietrzyk, Joanna
    Kamecka, Anna
    Milczarek, Magdalena
    MATERIALS, 2020, 13 (16)
  • [27] Rational design of dicarboxylato platinum(II) complexes with purinemimetic ligands as novel anticancer agents
    Hoffmann, Kamil
    Wisniewska, Joanna
    Wojtczak, Andrzej
    Sitkowski, Jerzy
    Denslow, Agnieszka
    Wietrzyk, Joanna
    Jakubowski, Mateusz
    Lakomska, Iwona
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2017, 172 : 34 - 45
  • [28] Synthesis, crystal structures, DNA binding and cytotoxicity of two novel platinum(II) complexes containing 2-(hydroxymethyl)pyridine and pyridine-2-carboxylate ligands
    Icsel, Ceyda
    Yilmaz, Veysel T.
    Golcu, Aysegul
    Ulukaya, Engin
    Buyukgungor, Orhan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (07) : 2117 - 2122
  • [29] Synthesis, structures, and anticancer potentials of four platinum (II) complexes with benzopyran derivatives targeting mitochondria
    Liu, Jun-Hong
    Wei, Zu-Zhuang
    Yang, Lin
    Qin, Qi-Pin
    Liu, Xian-Xian
    Tan, Ming-Xiong
    INORGANIC CHEMISTRY COMMUNICATIONS, 2020, 122
  • [30] Synthesis, crystal structures, in vitro biological evaluation of zinc(II) and bismuth(III) complexes of 2-acetylpyrazine N(4)-phenylthiosemicarbazone
    Li, Ming-Xue
    Zhang, Li-Zhi
    Yang, Min
    Niu, Jing-Yang
    Zhou, Jing
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (07) : 2418 - 2423